Profile | GDS2987 / Hs.490139-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 8.7 | 30 |
GSM215244 | HMVEC_vehicle_rep2 | 10.5 | 27 |
GSM215253 | HMVEC_vehicle_rep3 | 3.7 | 13 |
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | 10.5 | 25 |
GSM215344 | HMVEC_atorvastatin_rep2 | 8 | 20 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 39.2 | 58 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | ||
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | 3.8 | 14 |
GSM215295 | HMVEC_SLx2119_rep2 | 27.3 | 48 |
GSM215296 | HMVEC_SLx2119_rep3 | 28.1 | 43 |
GSM215297 | PASMC_vehicle_rep1 | 5.2 | 8 |
GSM215298 | PASMC_vehicle_rep2 | 44.7 | 56 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 28.4 | 45 |
GSM215312 | PASMC_atorvastatin_rep2 | 49.3 | 59 |
GSM215313 | PASMC_atorvastatin_rep3 | 25.7 | 37 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 23 | 41 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 6 | 11 |
GSM215327 | PASMC_SLx2119_rep1 | 14.7 | 26 |
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | 23.4 | 42 |
GSM215330 | Fibroblasts_vehicle_rep1 | 22.5 | 46 |
GSM215331 | Fibroblasts_vehicle_rep2 | ||
GSM215332 | Fibroblasts_vehicle_rep3 | 23.3 | 57 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 3.4 | 9 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 18 | 45 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 29.4 | 56 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | ||
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | ||
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 10.6 | 29 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 0.6 | 2 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 9.8 | 27 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 20.6 | 46 |